RSS
14 Jul 2021

RegeneRx JV Updates RGN-259 Regulatory Progress for Dry Eye Syndrome

Author: admintech | Filed under: Press Release

ROCKVILLE, Md., July 14, 2021 /PRNewswire/ — RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration has released an update from its U.S. joint venture, ReGenTree LLC, regarding its…

This entry was posted on Wednesday, July 14th, 2021 at 7:14 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»